Video

Episode 6 - Discussing the Pathophysiology of MS

According to Dr. Patricia K. Coyle, the nature of unmanaged multiple sclerosis (MS) produces recurrent attacks on the brain and spinal cord, which results in focal inflammatory lesions that can be visualized with magnetic resonance imaging (MRI). Unfortunately, 80-90% of lesions that form are silent and cannot be detected on the neurological examination, which exposes patients to a greater burden of disease and an increased risk of dysfunction. Furthermore, depending on which neurological components are affected, patients are at heightened risk for a broad suite of deficits, including weakness, spasticity, sensory loss, and cognitive issues. As the disease progresses, symptomatology may include bladder disruption, walking abnormalities, tremor, and fatigue.


Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Cathy Eng, MD, FACP, FASCO
Leigh Maria Ramos-Platt, MD
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo